Lung Cancer Center, Atlanta

Your treatment options

Lung Cancer Center

Lung cancer is often diagnosed after it has progressed to an advanced stage. That’s why it is important to have a clinical team devoted to treating lung cancer patients, a team with the expertise to tailor a treatment plan specific to your tumor type, stage, genomic markers and other needs. New treatments are constantly being developed in this era of precision, genomic-based cancer care.

At the Cancer Treatment Centers of America® (CTCA) Lung Cancer Center in Atlanta, our singular focus enables our oncologists to stay up to date on new and emerging treatments and technologies, allowing us to help you make informed decisions about the options available to treat not just the disease but the side effects that may result. Clinical trials in immunotherapy, cryotherapy and other areas of innovation may be among the options available. Having a team of lung cancer experts collaborating daily, all under one roof, allows us to assemble a detailed treatment plan more quickly and more efficiently.

Our Lung Cancer Center doctors

Daniel Miller - General Thoracic Surgeon

Daniel L. Miller

General Thoracic Surgeon, CTCA Atlanta

Christopher Parks - Interventional Pulmonologist

Christopher Parks

Interventional Pulmonologist, CTCA Atlanta

Jason Beland - Chair, CTCA Department of Radiology

Jason Beland

Chair, CTCA Department of Radiology

Charles Fulp - Director of Interventional Radiology

Charles Fulp

Interventional Radiologist, CTCA Atlanta

Henry Krebs - Interventional Radiologist

Henry Krebs, MD

Interventional and Diagnostic Radiologist, CTCA Atlanta

Judy Sequeira - Medical Director of Pathology and Laboratory

Judy Sequeira

Vice Chief of Staff and Medical Director of Pathology and Laboratory, CTCA Atlanta


Herbert L. Duvivier

Hematologist and Medical Oncologist

Learn more

A comprehensive team approach

The oncologists, surgeons and other doctors at the CTCA® Lung Cancer Center in Atlanta are part of a wider team of multidisciplinary cancer experts who work together, collaborating daily with the patient and one another, all under one roof. Theirs is a synergy that comes from combining years of expertise and varied skills toward a single cause—treating lung cancer patients. Each patient’s Lung Cancer Center care team is led by a medical oncologist and coordinated by a care manager devoted to the many details needed to help patients achieve their treatment goals and maintain their quality of life. Our lung cancer pathologists also play a key role in diagnosing and staging the disease, to better pinpoint the treatment options available.

Various other doctors and clinicians may be assigned to your care team to help you meet your treatment goals and manage lung cancer-related side effects. For example, depending on your lung cancer type, stage and recommended treatment plan, your care team may include surgical and/or radiation oncologists, interventional pulmonologists, oncology nurses and a host of supportive care clinicians, all joining together to craft a personalized care plan with a commitment to comprehensive care. To help you maintain your strength and stamina during treatment, your care team may recommend a number of evidence-informed supportive therapies, including nutritional advicepsychological counseling, physical therapy and spiritual support. A nurse practitioner trained in smoking cessation techniques is also available to offer strategies for quitting tobacco for those who request it. This whole-person focus is at the heart of the center’s dedication to comprehensive, personalized care.

Quality of life

Lung cancer patients often experience treatment-related side effects including fatigue, appetite loss, pain, nausea or neuropathy. To help you manage those side effects and maintain your strength and stamina throughout treatment, your team of cancer experts may include various integrative care experts, including a dietitian, naturopathic provider, physical therapist, mind-body provider, spiritual counselor and more.

Learn more about how integrative cancer treatment may help you manage your lung cancer journey

Lung cancer clinical trials

Our Lung Cancer Center in Atlanta is dedicated to offering innovative, leading-edge treatment options. One way to do that is by offering carefully selected lung cancer clinical trials in areas like immunotherapy, interventional pulmonology and chemotherapy. Clinical trials are an essential testing ground for measuring the effectiveness of drugs and other treatments before they can win FDA approval. Trials may offer participants new options that would otherwise be unavailable to them. Find out about the various lung cancer trials underway at CTCA.

Clinical trials Q & A

Are clinical trials only available to patients who have exhausted other lung cancer treatment options?

Lung cancer patients may qualify to participate in a clinical trial at any stage of their treatment journey. Some patients may join a clinical trial when they first start treatment, in conjunction with standard therapy, on the chance it may offer improved outcomes. Other trials are designed for lung cancer patients who have not responded adequately to conventional treatments. Your Lung Cancer Center oncologist will discuss the options and risks, and explain the various protocols involved.

How does CTCA select the trials it offers?

At CTCA, our Lung Cancer Center experts never stop searching for innovative ways to treat lung cancer. Offering carefully selected clinical trials helps us fulfill that mission. The new generation of precision drugs is generally designed to deliver more targeted, less toxic therapies. Our Lung Cancer Center oncologists decide to participate as a clinical trial site only after careful consideration of the relative benefit to patients.

Who may benefit from lung cancer clinical trials?

The answer is based on a case-by-case analysis of each lung cancer patient. This is a time of rapid scientific advances in lung cancer treatment. New surgical techniques are being developed with a goal of attacking lung tumors while reducing the amount of trauma to healthy tissue. Meanwhile, a new generation of lung cancer therapies is designed to attack tumors that have specific genomic mutations. These new targeted treatments may be more effective and cause fewer side effects than traditional chemotherapy. But they are so specialized that only a limited subset of lung cancer patients qualifies for participation. The immunotherapy drug nivolumab, for example, is approved for patients with non-squamous non-small cell lung cancer who have already tried platinum-based chemotherapy or EGFR- or ALK-targeted agents. Genomic tumor testing may determine whether you are a candidate. Other factors—such as your cancer mutations and stage, how you have responded to past treatments and other individual considerations—may also determine whether you qualify for specific trials

How do I find out whether a specific clinical trial may benefit me?

Your Lung Cancer Center oncologist and care team may recommend a trial depending on your individual needs and treatment goals. For general questions, contact an Oncology Information Specialist at 888-841-9129.

Cancer Treatment Centers of America Locations, Atlanta – CTCA

Where we are located

CTCA Atlanta

Lung Cancer Center
600 Celebrate Life Pkwy.
Newnan, GA 30265
New Patients: 833-650-7781
Current Patients:;: 844-316-8868

New research

Offering clinical trials on new and emerging cancer treatment options.

View our clinical trials

What’s your risk?

Assess your cancer risk and take control

Assess your cancer risk

Insurance plans

We accept a wide range of insurance plans.

Verify your insurance